Signal Transduction and Chromatin, 2004
HIF-1: master and commander of the hypoxic world
Phosphodiesterase inhibitors as anti-cancer drugs
Drug development for ovarian hyper-stimulation and anti-cancer treatment: blocking of gonadotropin signaling for epiregulin and amphiregulin biosynthesis
The signaling pathways in tissue morphogenesis: a lesson from mice with eye-open at birth phenotype
An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis
Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system
DNAzymes as molecular agents that manipulate Egr-1 gene expression
Surviving the kiss of death
Cytotoxic lymphocytes; instigators of dramatic target cell death
Modulation of poly(ADP-ribosylation) in apoptotic cells
The role of Raf kinase inhibitor protein (RKIP) in health and disease
Hedgehog signalling in foregut malignancy
New anticancer strategies targeting HIF-1
Nuclear factor-κB: a friend or a foe in cancer?
Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras -transformed human mammary epithelial cells
Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention
Effect of chemopreventive agents on glutathione S -transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition
Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake
Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells
Histone deacetylase inhibitors open new doors in cancer therapy
Isothiocyanates as novel cytotoxic and cytostatic agents: molecular pathway on human transformed and non-transformed cells
Antioxidants regulate normal human keratinocyte differentiation
CBP and p300: HATs for different occasions
Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders
High mobility group box 1 protein, a cue for stem cell recruitment
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections
DNA methylation and breast cancer
Acetylation of nuclear receptors in cellular growth and apoptosis
Epigenetic control of CIITA expression in leukemic T cells
Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy
Regulation at multiple levels of NF-κB-mediated transactivation by protein acetylation
Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies
Histone deacetylase inhibition and estrogen signalling in human breast cancer cells
Epigenetic gene silencing in acute promyelocytic leukemia
Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression
Increased glutathione S -transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells